Invictus RG’s Edwards Lifesciences EW Stock Holding History

Invictus RG’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-7,368	Closed	-$343K	–	245
2018 Q1	$343K	Buy	+7,368	New	+$320K	0.23%	115
2016 Q4	–	Sell	-435	Closed	-$17K	–	673
2016 Q3	$17K	Buy	+435	New	+$16.4K	0.01%	576

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Invictus RG's EW Position: Q2 2018 in Review

Invictus RG sold out of Edwards Lifesciences (EW) in Q2 2018, closing a stake of 7,368 shares — an estimated $343K sold.

Invictus RG first reported a position in EW in Q3 2016 and held it in 2 quarters. The position peaked at $343K in Q1 2018. 838 funds tracked by Wall St. Rank hold EW as of Q2 2018.

Invictus RG reported no remaining Edwards Lifesciences position as of Q2 2018 after selling out during the quarter.
Invictus RG sold 7,368 Edwards Lifesciences shares in Q2 2018, an estimated $343K.
Invictus RG first reported a position in Edwards Lifesciences in Q3 2016 and held it in 2 quarters.
Invictus RG's Edwards Lifesciences position peaked at $343K in Q1 2018.
838 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2018.

Based on Invictus RG's 13F filing for Q2 2018, filed 13 Aug 2018.